80% of Tuberculosis Patients Don’t Have Persistent Cough
A study of more than 600,000 individuals shows that 4 in 5 with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
A study of more than 600,000 individuals shows that 4 in 5 with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
High-dose inhaled nitric oxide (iNO) therapy may improve oxygenation and reduce the risk of ARDS-related mortality among critically ill Black patients with COVID-19, according to a first-of-its-kind study published in the American Journal of Respiratory and Critical Care Medicine.
The recent surge in influenza, COVID-19, and other respiratory viruses can trigger cardiovascular complications from fever, dehydration, and increased inflammation, and Mount Sinai doctors are seeing a rise in these cases in all age groups.
Fungal pneumonia caused by Pneumocystis is difficult study, but scientists have developed a promising new model using precision-cut slices of lung tissue to allow lab cultures of the fungus.
An FDA advisory committee determined that phenylephrine, common in brands like Benadryl and Mucinex, is ineffective as a nasal decongestant.
Ohio health officials have confirmed cases of mumps and measles in the state, including a child who traveled through Cincinnati/Northern Kentucky International Airport (CVG).